BreezeMeds vs RxActivate: Pricing and Intake Compared
BreezeMeds vs RxActivate: BreezeMeds shows specific starting prices for injectable and oral GLP-1s while RxActivate gates pricing behind a medical eligibility flow. Early verdict: BreezeMeds is more transparent on starting prices; RxActivate requires the intake questionnaire and contact information before revealing plan details.
See BreezeMeds starting prices and intake
How pricing transparency compares
BreezeMeds lists semaglutide injection from $199/mo, tirzepatide injection from $299, and oral options displayed from $399, with an additional $169 figure appearing without clear product association. RxActivate displays no price, medication fee, membership fee, shipping charge, cancellation term or billing commitment before the contact-information gate; pricing is gated behind completion of the medical eligibility questionnaire and submission of name, email and phone number.
Start RxActivate eligibility quiz
Offerings and availability: injectable and oral options
Both providers offer clinician-reviewed online weight-management treatment and state-based screening. BreezeMeds explicitly lists semaglutide injection, tirzepatide injection, and oral semaglutide and oral tirzepatide among its features. RxActivate highlights clinician-matched GLP-1 plans and a two-minute eligibility questionnaire but does not display product lists with prices before intake.
Onboarding flow and lead capture
BreezeMeds presents pricing and product cues directly on landing content, though some fees and billing commitments were not fully visible and a $169 offer is not clearly tied to a product. RxActivate requires users to complete an eligibility flow that requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening; it then requires first name, last name, email and phone number before revealing any plan or price. RxActivate confirmed Alabama as serviceable in a synthetic test.
Review BreezeMeds intake details
Regulatory and medication notes
Both sources state treatment is available only when a licensed clinician determines it is medically appropriate and note that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds explicitly cautions that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. RxActivate includes the same regulatory note about approval status and interchangeability.
Direct comparison table
| Criteria | BreezeMeds | RxActivate |
|---|---|---|
| Pricing visibility | Semaglutide injection from $199; tirzepatide injection from $299; oral from $399; $169 figure unclear | No prices shown before completing questionnaire and providing contact info |
| Product offerings | Semaglutide injection, tirzepatide injection, oral semaglutide and oral tirzepatide listed | Clinician-matched GLP-1 plans; product and price gated behind intake |
| Onboarding | Online intake and personalized treatment plan with pricing visible on landing | Two-minute eligibility questionnaire then contact-info gate before plan or price |
| Lead capture | Landing shows pricing and prompts for intake | Requires name, email, phone before revealing price or plan |
| Service availability | States not fully listed; users must confirm state availability before enrollment | Alabama confirmed in synthetic test; state and safety screening in flow |
| Regulatory notes | Compounded meds not FDA-approved; approval status must be confirmed | Compounded meds not FDA-approved; approval status must be confirmed |
Pros and cons in direct comparison
BreezeMeds: Pros include visible starting prices, injectable and oral GLP-1 options listed, online intake and discreet home delivery claims. Cons include an unclear $169 offer, incomplete visibility into fees and billing commitments, and the need to confirm compounding and FDA status.
Compare BreezeMeds options now
RxActivate: Pros include a functioning eligibility flow, clinician-matched plans and a confirmed service test for Alabama. Cons are that pricing and membership terms are not disclosed before lead capture and no medication, membership or shipping fees are visible prior to providing contact information.
Proceed with RxActivate intake
Conclusion: Which to choose in the BreezeMeds vs RxActivate comparison
In the BreezeMeds vs RxActivate comparison, BreezeMeds provides more immediate price transparency with listed starting prices for injectable and oral GLP-1s, while RxActivate requires the two-minute eligibility questionnaire and contact information before revealing any price or plan. Both require clinician review for treatment and note that compounded medications are not FDA-approved.
Choose BreezeMeds if you want visible starting prices and a landing-page presentation of injectable and oral GLP-1 options. Choose RxActivate if you prefer to complete an eligibility flow and receive clinician-matched plans after providing contact information.